BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22551)

  • 21. The occurrence of an unusual tubular organelle in surface epithelial cells of the mouse ascending colon after injection of diazo-oxo-norleucine.
    Michaels JE
    Anat Rec; 1980; 196(4):413-20. PubMed ID: 7396231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport mechanisms of 6-diazo-5-oxo-L-norleucine in Escherichia coli K-12.
    Williams MV
    Microbiologica; 1982 Jan; 5(1):57-61. PubMed ID: 7050636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro.
    Aydelotte MB; Kochhar DM
    Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamine and glutamate metabolism in normal and heat shock conditions in Drosophila Kc cells: conditions supporting glutamine synthesis maximize heat shock polypeptide expression.
    Sanders MM; Kon C
    J Cell Physiol; 1992 Mar; 150(3):620-31. PubMed ID: 1347046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of large neutral amino acid-induced release of preloaded L-glutamine from rat cerebral capillaries in vitro: effects of ammonia, hepatic encephalopathy, and gamma-glutamyl transpeptidase inhibitors.
    Hilgier W; Puka M; Albrecht J
    J Neurosci Res; 1992 Jun; 32(2):221-6. PubMed ID: 1357187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenicity of D- and L-azaserine, 6-diazo-5-oxo-L-norleucine and N-(N-methyl-N-nitroso-carbamyl)-L-ornithine in the Salmonella test system.
    Staiano N; Everson RB; Cooney DA; Longnecker DS; Thorgeirsson SS
    Mutat Res; 1980 Dec; 79(4):387-90. PubMed ID: 7003378
    [No Abstract]   [Full Text] [Related]  

  • 27. Glutamine synthetase and glutaminase activities in various hepatoma cells.
    Matsuno T; Hirai H
    Biochem Int; 1989 Aug; 19(2):219-25. PubMed ID: 2573354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of diazo-oxo-norleucine on cell kinetics and odontoblast differentiation in cultured embryonic mouse molars.
    Olive M; Ruch JV
    Arch Oral Biol; 1982; 27(6):505-11. PubMed ID: 6956264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of concentric saccules in murine parietal cells after injection of diazo-oxo-norleucine.
    Michaels JE
    Anat Rec; 1979 Apr; 193(4):775-90. PubMed ID: 218477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of 6-diazo-5-oxo-L-norleucine, a glutamine analogue, on the structure of the major cartilage proteoglycan synthesized by cultured chondrocytes.
    Clark CC; Richards CF; Pacifici M; Iozzo RV
    J Biol Chem; 1987 Jul; 262(21):10229-38. PubMed ID: 3112139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of morphogenetic cell interactions by 6-diazo-5-oxo-norleucine (DON).
    Ekblom P; Lash JW; Lehtonen E; Nordling S; Saxén L
    Exp Cell Res; 1979 Jun; 121(1):121-6. PubMed ID: 446523
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition by glutamate of phosphate-dependent glutaminase of rat kidney.
    Shapiro RA; Morehouse RF; Curthoys NP
    Biochem J; 1982 Dec; 207(3):561-6. PubMed ID: 6131666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
    Huber KR; Rosenfeld H; Roberts J
    Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of mandibular growth and induction of cleft palate by diazo-oxo-norleucine (DON) in the rat.
    Diewert VM; Pratt RM
    Teratology; 1979 Aug; 20(1):37-51. PubMed ID: 515963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport and membrane binding of the glutamine analogue 6-diazo-5-oxo-L-norleucine (DON) in Xenopus laevis oocytes.
    Taylor PM; Mackenzie B; Hundal HS; Robertson E; Rennie MJ
    J Membr Biol; 1992 Jun; 128(3):181-91. PubMed ID: 1501246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affinity labeling of rat kidney gamma-glutamyl transpeptidase by 6-diazo-5-oxo-D-norleucine.
    Inoue M; Horiuchi S; Morino Y
    Eur J Biochem; 1979 Aug; 99(1):169-77. PubMed ID: 39760
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrastructure of the expected fusion zone in rat fetuses with diazo-oxo-norleucine (DON)-induced cleft palate.
    Morgan PR; Pratt RM
    Teratology; 1977 Jun; 15(3):281-9. PubMed ID: 882917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deamidation of glutamine by increased plasma gamma-glutamyltransferase is a source of rapid ammonia formation in blood and plasma specimens.
    da Fonseca-Wollheim F
    Clin Chem; 1990 Aug; 36(8 Pt 1):1479-82. PubMed ID: 1974830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase.
    Conti F; Minelli A
    J Histochem Cytochem; 1994 Jun; 42(6):717-26. PubMed ID: 7910617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diazo-oxo-norleucine (DON)-induced alterations in the extracellular matrix of the mouse tooth germ.
    Hurmerinta K; Thesleff I
    Cell Differ; 1982 Apr; 11(2):107-13. PubMed ID: 7066992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.